Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2004. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4260201000001112 | Cetylpyridinium chloride+ascorbic acid 1.4mg/125mg lozenge | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 8740501000001112 | Cetylpyridinium chloride+ascorbic acid 1.4mg/125mg lozenge | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Cetylpyridinium chloride+ascorbic acid 1.4mg/125mg lozenge | Is a | Product containing cetylpyridinium | false | Inferred relationship | Existential restriction modifier | ||
| Cetylpyridinium chloride+ascorbic acid 1.4mg/125mg lozenge | Availability | Discontinued product | false | Additional relationship | Existential restriction modifier | ||
| Cetylpyridinium chloride+ascorbic acid 1.4mg/125mg lozenge | Has active ingredient | Skin anti-infective | false | Inferred relationship | Existential restriction modifier | ||
| Cetylpyridinium chloride+ascorbic acid 1.4mg/125mg lozenge | Has active ingredient | Cationic surfactant | false | Inferred relationship | Existential restriction modifier | ||
| Cetylpyridinium chloride+ascorbic acid 1.4mg/125mg lozenge | Has active ingredient | Cetylpyridinium | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Merovit lozenge | Is a | False | Cetylpyridinium chloride+ascorbic acid 1.4mg/125mg lozenge | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR